| Business Dump |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Home and Family > Retirement > Not Saving For Retirement Is People's Biggest Money Worry |
|
Business Dump - Not Saving For Retirement Is People's Biggest Money Worry
Not saving for retirement is people’s biggest money worry. All most as many people said that not meeting monthly expenses is their biggest wo According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product rry. A poll of 1,157 people was conducted by the AnswerBank which found that only 10 per cent of people polled are worried about paying their ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in mortgage off. Not having enough money to retire with is people’s biggest money worry, meeting monthly expenses is also high on people’s mon lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ey concerns list. This is hardly surprising considering the rises in council tax, gas, electricity and petrol prices faced by consumers this here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ear. The poll conducted by the AnswerBank found 31 per cent of people are most concerned about not saving for retirement closely followed b d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro y 30 per cent of people who are worried about not being able to meet monthly expenses. The increase in outgoings a household has means the ‘ ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc spare’ money people have to spend each month has decreased making it even harder to save for retirement. Only 6 per cent of the people polle easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi d said their main worry was their overdraft which will have bank managers twitching in their seats as overdrafts are readily used by the publ nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically c. Just over 10 per cent of people said paying off their mortgage was their main concern. Gas bills have risen three times in the last year, and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ customers of British Gas will have an added average of ?150 to their utility bills. Petrol has also reached record highs with people having ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi to pay ?1 a litre or more in many garages. The 50 per cent interest increase on mortgage payments has hit buyers hard. Council tax has risen ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a sharply by 16 percent and water bills have increased by 24 per cent making monthly expenditures bigger than ever. To survive these increasi dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod g costs a person must either cut back dramatically on their spending or they may end up knee-high in debt. It now becomes apparent as to why cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin bankruptcy is at an all time high in the UK; credit is so easily obtained but not so easily repaid. These figures do not bode well for credit tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ors as the public frets over meeting monthly living costs. Not being able to save for retirement is very worrying for the public, first tim t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel e buyers are taking out 100 per cent mortgages due the huge increase in the price of houses which they could be repaying into their sixties w ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust en they should be close to retiring. It means that people are going to have much less money, if any, to save. What are your biggest money wo y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products rries? Total number of people surveyed: 1157
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Venture Capital Angel Investors Don't Know Jack Senior Life Settlements-Understanding the Potential Tax Consequences Nokia 6102, 6103 and 6102i; Camera Phone
|